"Bahrain Pharmaceuticals & Healthcare Report Q3 2013" Published
Bahrain's wealth will continue to attract research-based pharmaceutical manufacturers. We therefore expect the value of the country's patented drug market to continue on its steady upward trajectory. However, annual growth rates of its generic counterpart will be considerably more impressive, despite coming off a very low base, as leading drugs lose their patent protection
View full press release